Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: Influence of linker length and flexibility

被引:271
作者
Reinke, Ashley A. [1 ]
Gestwicki, Jason E. [1 ]
机构
[1] Univ Michigan, Inst Life Sci, Dept Pathol, Ann Arbor, MI 48109 USA
关键词
Alzheimer's disease; neurodegeneration; protein misfolding; thioflavin T; SMALL-MOLECULE INHIBITORS; ALZHEIMERS-DISEASE; FIBRIL FORMATION; BINDING-SITES; PEPTIDE; PROTEIN; MECHANISM; OLIGOMERS; PROTOFIBRILS; POLYPHENOLS;
D O I
10.1111/j.1747-0285.2007.00557.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Self-assembly of amyloid beta into fibrillar plaques is characteristic of Alzheimer's disease and oligomers of this peptide are believed to be involved in neurodegeneration. Natural organic dyes, such as congo red and curcumin, bind tightly to amyloid beta and, at higher concentrations, block its self-assembly. The ability of these molecules to prevent amyloid accumulation has generated interest in understanding which of their structural features contribute to inhibitory potency. In general, amyloid beta ligands tend to be flat, planar molecules with substituted aromatic end groups; however, a comprehensive structure-activity study has not been reported. To better understand these ligands, we surveyed the effect of three prominent features on inhibition of amyloid aggregation: the presence of two aromatic end groups, the substitution pattern of these aromatics, and the length and flexibility of the linker region. We found that modification of any one of the modules has profound effects on activity. Further, we report that the optimal length of the linker lies within a surprisingly narrow regime (6-19 angstrom). These results offer insight into the key chemical features required for inhibiting amyloid beta aggregation. In turn, these findings help define the nature of the docking site for small molecules on the amyloid beta surface.
引用
收藏
页码:206 / 215
页数:10
相关论文
共 56 条
  • [1] Combinatorial synthesis and antibacterial evaluation of an indexed chalcone library
    Ansari, FL
    Nazir, S
    Noureen, H
    Mirza, B
    [J]. CHEMISTRY & BIODIVERSITY, 2005, 2 (12) : 1656 - 1664
  • [2] Globular amyloid β-peptide1-42 oligomer -: a homogenous and stable neuropathological protein in Alzheimer's disease
    Barghorn, S
    Nimmrich, V
    Striebinger, A
    Krantz, C
    Keller, P
    Janson, B
    Bahr, M
    Schmidt, M
    Bitner, RS
    Harlan, J
    Barlow, E
    Ebert, U
    Hillen, H
    [J]. JOURNAL OF NEUROCHEMISTRY, 2005, 95 (03) : 834 - 847
  • [3] Structure and dynamics of parallel β-sheets, hydrophobic core, and loops in Alzheimer's Aβ fibrils
    Buchete, Nicolae-Viorel
    Hummer, Gerhard
    [J]. BIOPHYSICAL JOURNAL, 2007, 92 (09) : 3032 - 3039
  • [4] CARRPIGLIA P, 2007, CHEM BIOL DRUG DES, V69, P111
  • [5] Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders
    Caughey, B
    Lansbury, PT
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2003, 26 : 267 - 298
  • [6] Design, synthesis, and structure-activity relationship of novel thiophene derivatives for β-amyloid plaque imaging
    Chandra, R
    Kung, MP
    Kung, HF
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (05) : 1350 - 1352
  • [7] Therapeutic approaches to protein-misfolding diseases
    Cohen, FE
    Kelly, JW
    [J]. NATURE, 2003, 426 (6968) : 905 - 909
  • [8] Targeting the neurotoxic species in Alzheimer's disease:: inhibitors of Aβ oligomerization
    De Felice, FG
    Vieira, MNN
    Saraiva, LM
    Figueroa-Villar, JD
    Garcia-Abreu, J
    Liu, R
    Chang, L
    Klein, WL
    Ferreira, ST
    [J]. FASEB JOURNAL, 2004, 18 (12) : 1366 - 1372
  • [9] The structural biology of protein aggregation diseases: Fundamental questions and some answers
    Eisenberg, David
    Nelson, Rebecca
    Sawaya, Michael R.
    Balbirnie, Melinda
    Sambashivan, Shilpa
    Ivanova, Magdalena I.
    Madsen, Anders O.
    Riekel, Christian
    [J]. ACCOUNTS OF CHEMICAL RESEARCH, 2006, 39 (09) : 568 - 575
  • [10] Heat shock proteins 70 and 90 inhibit early stages of amyloid β-(1-42) aggregation in vitro
    Evans, Christopher G.
    Wisen, Susanne
    Gestwicki, Jason E.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (44) : 33182 - 33191